Viking Therapeutics: Prepping For A Critical 2026

Viking Therapeutics advances oral and injectable VK2735 for obesity with strong cash, pipeline depth, and key 2026 catalysts.
Business Daily Africa on MSN

Gulf Energy pushes for railway transport of Turkana crude oil

Proposed construction of the railway is a shift from the earlier plan to build an export pipeline from the oilfields to the port of Lamu.

In an age of streaming and AI slop, parents and researchers worry about a shrinking PBS Kids

But when he looks over and sees the PBS Kids logo, he feels he can stand down. “It is one thing that we don’t have to worry ...
The Manila Times

All Approved Indications of Five Akeso's Innovative Drugs Included in China's Latest NRDL: Featuring Two First-in-Class Bispecifics with New First-Line Indications and Three ...

Akeso, Inc. (9926.HK) ('Akeso' or the 'Company') announced the successful inclusion of all five of the Company's self-developed innovative drugs into the updated National Reimbursement Drug List (NRDL ...